Inhibrx Biosciences, Inc. - COM (INBX)

Historical Portfolio Holders from Q3 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
37.7 M
Holdings value Q1 2024
$1.32 B
Value change Q1 2024
-$107 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
120
Number of buys Q1 2024
60
Number of sells Q1 2024
-63
Average buys Q1 2024 %
+0.004%
Average sells Q1 2024 %
-0.002%
CUSIP
45720L107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 37.7 M $1.32 B -$107 M $34.96 120
2023 Q4 40.2 M $1.53 B +$14.1 M $38.00 123
2023 Q3 39 M $716 M +$50.3 M $18.35 108
2023 Q2 36 M $935 M -$5.28 M $25.96 105
2023 Q1 36.6 M $691 M +$11.2 M $18.87 106
2022 Q4 35.9 M $885 M +$188 M $24.64 113
2022 Q3 28.5 M $511 M +$56.8 M $17.95 99
2022 Q2 26 M $295 M +$234 K $11.35 91
2022 Q1 24.3 M $541 M +$6.6 M $22.28 94
2021 Q4 23.2 M $1.01 B +$122 M $43.67 95
2021 Q3 20.4 M $681 M +$33.5 M $33.31 65
2021 Q2 19.5 M $538 M +$90 M $27.52 59
2021 Q1 15.9 M $318 M -$14.8 M $20.07 53
2020 Q4 15.2 M $501 M +$54.7 M $32.97 50
2020 Q3 13.8 M $249 M +$249 M $18.00 32